2024-512475-12-01RecruitingPhase 4
Prevention of thromboembolism during pancreatic cancer treatments - link to prognosis and relapse of the disease.
Thrombosis prophylaxis and coagulation activation during neoadjuvant treatment in pancreatic cancer - Association to prognosis and recurrence.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 27 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Neoadjuvant-treated pancreatic cancer patients are at increased risk of thrombosis. Our aim is to investigate the impact of thromboprophylaxis administered during neoadjuvant treatments on the risk of vascular events and survival prognosis in pancreatic cancer patients in a randomized prospective study.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 214 (estimated)
- First submitted
- 30 Oct 2024
- Start date
- 27 Nov 2024
- Lead sponsor
- HUS-Yhtymae
- Diseases
- Pancreatic cancer
- EU CT number
- 2024-512475-12-01
- EudraCT number
- 2019-002496-33
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 214
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Who cannot take part
Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.
Other illness
- The study excludes patients, if they have contraindications for using tinzaparin, are already on anticoagulant medication, have had any other active cancer in the past five years or have severe kidney failure or bleeding tendencies.
Who the study is looking for
- An adult pancreatic cancer patient for whom neoadjuvant treatments are being planned due to pancreatic cancer.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| HUS-Yhtymae | Helsinki | Finland | Recruiting |
| Oulu University Hospital | Oulu | Finland | Recruiting |
| Tampere University Hospital | Tampere | Finland | Recruiting |
| Turku University Hospital | Turku | Finland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.